PT  - JOURNAL ARTICLE
AU  - Ojulari, Lekan Sheriff
AU  - Sulaiman, Swabirah Enimire
AU  - Ayinde, Taofeek Olanrewaju
AU  - Kadir, Eniola Riskat
TI  - Handgrip strength as a screening tool for diabetes in resource-constrained settings: a potential solution to overcome barriers to diagnosis
AID  - 10.1101/2023.10.19.23297260
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.10.19.23297260
4099  - http://medrxiv.org/content/early/2023/10/20/2023.10.19.23297260.short
4100  - http://medrxiv.org/content/early/2023/10/20/2023.10.19.23297260.full
AB  - Background Information Diabetes mellitus is an escalating global health concern, especially in low and middle-income countries. The high cost and inaccessibility of diagnostic tools in resource-constrained settings have heightened the need for alternative screening methods. Handgrip strength (HGS), a measure of muscle strength, emerges as a potential non-invasive and affordable screening tool for diabetes, particularly in areas with limited healthcare access.Objective To investigate the relationship between handgrip strength and blood glucose regulation in non-diabetic young adults and to provide valuable insights into the potential of handgrip strength as a preventive and affordable approach to managing diabetes.Methods A cross-sectional study was conducted involving 59 students (aged 18-21) from the University of Ilorin, Nigeria. Handgrip strength was measured using a dynamometer, and its relationship with blood glucose regulatory markers, such as fasting blood glucose, 2-hour post-prandial glucose, and HbA1c, was analyzed. Multiple regression models were utilized to examine the potential associations.Results Findings revealed significant associations between HGS and glucose regulation markers, particularly FBS, among males. In females, the relationship was evident only after adjusting for body mass index (BMI). Furthermore, a notable relationship between HGS and 2-hour post-prandial glucose levels was observed in females but not in males. However, no significant associations were found between HGS and serum insulin levels across genders.Conclusion Our study introduces HGS as a practical and cost-effective screening tool for blood glucose regulation disorders, aligning with existing literature and offering a personalized approach to management. In resource-constrained settings, HGS becomes significant, addressing diagnostic barriers and potentially revolutionizing diabetes management. However, limitations include a small sample size of 59 students and restrictions to specific demographics, emphasizing the need for future studies in diverse populations to validate HGS’s efficacy in real-world, resource-constrained settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was collected from the Research Ethics Committee of the University of Ilorin Teaching Hospital, Ilorin Kwara state, with the reference number: UITH/CAT/189/VOL.21B /486. An informed consent was also obtained from the research subjects.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information Files